Skip to main content
. 2022 Sep 18;33(11):2250–2260. doi: 10.1111/jce.15657

Table 1.

Patients baseline characteristics, including differences between primary and satellite centers cohorts

Patients baseline characteristics All patients (n = 85) Primary center (n = 49) Satellite centers (n = 36) p
Male sex, no. (%) 57 (67%) 36 (73%) 21 (58%) 0.14
Age, year 70 [60–75] 71 [65–76] 66 [60–72] 0.04
Comorbidities, no. (%)
Hypertension 56 (66%) 34 (69%) 22 (61%) 0.43
Obesity – BMI > 30 30 (35%) 20 (41%) 10 (28%) 0.21
Sleep apnea 18 (21%) 11 (22%) 7 (19%) 0.74
Diabetes 15 (18%) 10 (20%) 5 (14%) 0.44
PM/ICD 12 (14%) 7 (14%) 5 (14%) 0.96
Prior stroke/TIA 4 (5%) 4 (8%) 0 (0%) 0.13
Structural heart disease, no. (%) 33 (39%) 23 (47%) 10 (28%) 0.07
Ischemic cardiomyopathy 18 (21%) 14 (29%) 4 (11%) 0.05
Dilated cardiomyopathy 8 (9%) 3 (6%) 5 (14%) 0.27
Rhythmic cardiomyopathy 4 (5%) 3 (6%) 1 (3%) 0.63
Hypertrophic cardiomyopathy 2 (2%) 2 (4%) 0 (0%) 0.51
Valvular disease 1 (1%) 1 (2%) 0 (0%) 1
CHA2DS2‐VASc score 2.5 [1–4] 3 [2–4] 2 [1–3] 0.08
LVEF, % 50 [41–60] 52 [41–60] 50 [45–57] 0.74
LA vol (ml) 165 ± 38 171 ± 40 159 ± 35 0.16
Atrial fibrillation type, no. (%)
Persistent 60 (71%) 36 (73%) 24 (67%) 0.50
Long‐standing persistent 25 (29%) 13 (27%) 12 (33%)
AF history, year 2.5 [1–4.5] 3 [1–6] 1 [1–4] 0.05
Arrhythmia max duration, mo
All patients 6 [3–12] 6 [2–12] 8 [5–12] 0.17
Long‐standing persistent patients 12 [12–30] 22 [12–36] 12 [12–12] 0.01

Note: Values are mean ± standard deviation, median [interquartile range], or no. (%).

Continuous data were compared between primary and satellite centers using a nonparametric Wilcoxon test or Welch t‐test, according to their distribution. Categorical data were compared using χ 2 or Fisher test. All analyses were conducted using R version 4.0.0 (www.r-project.org). A p < 0.05 was considered statistically significant.

Abbreviations: BMI, body mass index; ICDs, implantable cardioverter defibrillators; LA, left atrium; LVEF, left ventricular ejection fraction; PMs, pacemakers; TIA, transient ischaemic attack.